Il18−/− mice show dyslipidemia at 6 weeks old, develop diabetes mellitus, and show high glucose and insulin levels and arteriosclerosis at 6 months old, and NAFLD or NASH at 48 weeks old [3, 8]. This evidence concerns the gene IL18 and metabolic dysfunction-associated steatotic liver disease.